Reproductive Medicine (Apr 2023)

Infertility Treatment and Hypertension in Pregnancy: The Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study

  • Mami Ishikuro,
  • Taku Obara,
  • Keiko Murakami,
  • Fumihiko Ueno,
  • Aoi Noda,
  • Tomomi Onuma,
  • Fumiko Matsuzaki,
  • Masahiro Kikuya,
  • Zen Watanabe,
  • Naomi Shiga,
  • Masahito Tachibana,
  • Noriyuki Iwama,
  • Hirotaka Hamada,
  • Masatoshi Saito,
  • Junichi Sugawara,
  • Hirohito Metoki,
  • Nobuo Yaegashi,
  • Shinichi Kuriyama

DOI
https://doi.org/10.3390/reprodmed4020010
Journal volume & issue
Vol. 4, no. 2
pp. 89 – 99

Abstract

Read online

Infertility treatment is a possible factor in hypertensive disorders of pregnancy (HDP). Identifying the characteristics of pregnant women who have undergone infertility treatment and have a potential risk for HDP is valuable for its prevention and treatment. Using data from 12,456 pregnant Japanese women from the Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study, the association between infertility treatment and HDP was analyzed. A multiple logistic regression model showed an association between infertility treatment and HDP (odds ratio, 1.34; 95% confidence interval, 1.05–1.72). In vitro fertilization/intracytoplasmic sperm injection were also associated with HDP. Moreover, these associations were observed even among women who were not overweight and did not smoke. The application of infertility treatment should be carefully considered, even among women with low modifiable risk factors.

Keywords